TG Therapeutics Inc

0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS

Case Summary
Company Name: TG Therapeutics Inc
Stock Symbol : NASDAQ: TGTX
Class Period Start: 09/15/2014
Class Period End: 10/12/2016
Lead Plaintiff motion: 03/07/2017
Date Filed: 01/06/2017
Type of Case: Securities Class Action
Court: U.S. District Court for the Southern District of New York
Summary:

Thieler Law Corp advises investors with losses exceeding $100,000 of the March 7, 2017 lead plaintiff deadline in a class action lawsuit filed against TG Therapeutics Inc (NASDAQ: TGTX) (“TG Therapeutics” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased TG Therapeutics Inc securities between September 15, 2014 and October 12, 2016, have until March 7, 2017 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased TG Therapeutics Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint focuses on whether TG Therapeutics and its executives violated federal securities laws by misrepresenting and/or omitting material information concerning the GENUINE Phase 3 trial for its proprietary combination of drug therapies TG-1101 and TGR-1202, assuring investors it was a “best-in-class treatment” that would be “successful” and “offer patients a novel chemo-free treatment option.”

On October 13, 2016, TG Therapeutics revealed that it would abandon Part II of the study, thus annulling its filed Special Protocol Assessment with the U.S. Food and Drug Administration (“FDA”) and cutting enrollment and increasing the likelihood that the FDA would not approve the combination treatment.

Following this news, NASDAQ: TGTX dropped by roughly 27% on October 17, 2016.

If you were negatively impacted by your investment in TG Therapeutics Inc securities between September 15, 2014 and October 12, 2016 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185

Transactions
Buy date (mm/dd/yyyy) Number of shares Price per share
Sell date (mm/dd/yyyy) Number of shares Price per share
Please wait...